Akademska digitalna zbirka SLovenije - logo
VSE knjižnice (vzajemna bibliografsko-kataložna baza podatkov COBIB.SI)
  • Successful treatment of severe atopic dermatitis with cysteinyl leukotriene receptor antagonist montelukast*
    Angelova-Fischer, Irena ; Tsankov, Nikolai
    Leukotrienes are potent proinflammatory mediators derived from of arachidonic acid through the 5 lipoxygenase pathway. Experimental data suggest a role for cysteinyl leukotrienes in the pathogenesis ... of atopic dermatitis and there is arationale for the use of pharmacological agents to antagonize their effects in the treatment of atopic dermatitis. We report 2 cases of severe atopic dermatitis successfully treated with montelukast as a single therapeutic agentin a daily dose of 10 mg for 8 weeks when corticosteroid treatment was contraindicated or failed to control the disease. Our observations suggest that montelukast may be used as an alternative steroid sparing medication for severe atopic dermatitis, especially in patients with associated asthma and rhinitis.
    Vir: Acta dermatovenerologica Alpina, Panonica et Adriatica. - ISSN 1318-4458 (Letn. 14, št. 3, 2005, str. 115-119)
    Vrsta gradiva - članek, sestavni del
    Leto - 2005
    Jezik - angleški
    COBISS.SI-ID - 20366041

    Povezava(-e):

    Digitalna knjižnica Slovenije - dLib.si

Vnos na polico